On Friday, Moderna said the additional funding will help pay for late-stage development, licensure of the vaccines and expanding clinical studies for additional subtypes of pandemic influenza to prevent other potential public health emergencies.

So it is ready to go, basically?

Obviously EXPROPRIATION is the right tool for the job.